Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase IIb, multi-centre, randomised, double-blind, active-controlled, trial comparing the neuropsychiatric adverse event profile of etravirine 400 mg q.d. versus efavirenz 600 mg q.d. in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in antiretroviral therapy-naïve HIV-1 infected subjects https://kusajili.com:443/Trial/GWtJxD4lSEiqg15TjVC4Qg%24a-phase-iib-multi-centre-randomised-double-blind-active-controlled-trial-comparing-the-neuropsychiatric-adverse-event-profile-o
I have read and accept the terms of use of the site and the Privacy Policy
Send your message